ArticleFrontiers in veterinary science2020
Upregulation of PD-L1 Expression by Prostaglandin E
Open access · goldAbstract read
In one paragraph
Article in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 43 citations in OpenAlex.
- Potential Host-Directed Mechanisms ofVeterinary sciences · 2026Article
- Bovine Respiratory Mycoplasmas and the Commensal-Pathogen Continuum: A Systematic Review of Vaccines and Diagnostic Approaches.Animals : an open access journal from MDPI · 2026Review
- Intermittent hypoxia drives lung microbiome-metabolome remodeling to create a pro-inflammatory landscape in murine OSAHS.Frontiers in microbiology · 2026Article
- Turning cold tumors into hot tumors to ignite immunotherapy.Molecular cancer · 2025Review
- RNA sequencing ofJournal of veterinary science · 2025Article
- Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.Signal transduction and targeted therapy · 2024Review
- Cancer cell metabolism and antitumour immunity.Nature reviews. Immunology · 2024Review
- The role, relevance and management of immune exhaustion in bovine infectious diseases.Heliyon · 2024Review
- Identification of genomic characteristics and selective signals in Guizhou black goat.BMC genomics · 2024Article
- Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system.Veterinary research · 2023Article
- Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.Journal of virology · 2023Article
- Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.Frontiers in oncology · 2023Review
- The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database.Frontiers in pharmacology · 2023Article
- Article
- Lipoproteins Are Potent Activators of Nuclear Factor Kappa B in Mammary Epithelial Cells and Virulence Factors inMicroorganisms · 2022Article
- Prostaglandin EInfection and immunity · 2022Article
- Metabolomic changes in polyunsaturated fatty acids and eicosanoids as diagnostic biomarkers in Mycobacterium avium ssp. paratuberculosis (MAP)-inoculated Holstein-Friesian heifers.Veterinary research · 2022Article
- Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.PloS one · 2022Article
- Metabolomic Changes in Naturally MAP-Infected Holstein-Friesian Heifers Indicate Immunologically Related Biochemical Reprogramming.Metabolites · 2021Article
- The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis.The Journal of veterinary medical science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 6 institutions in 1 country.
Shinya GotoDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Satoru KonnaiDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Yuki HiranoAgriculture Research Department, Animal Research Center, Hokkaido Research Organization, Shintoku, Japan.
Junko KoharaAgriculture Research Department, Animal Research Center, Hokkaido Research Organization, Shintoku, Japan.
Tomohiro OkagawaDepartment of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Naoya MaekawaDepartment of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Yamato SajikiDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Kei WatariDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Erina MinatoDepartment of Veterinary Clinical Medicine, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Atsuhi KobayashiDepartment of Veterinary Clinical Medicine, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Satoshi GondairaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Hidetoshi HiguchiSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Masateru KoiwaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Motoshi TajimaSchool of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
Eiji TaguchiShibetsu Animal Hospital, Shibetsu, Japan.
Ryoko UemuraDepartment of Veterinary Medical Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan.
Shinji YamadaDepartment of Antibody Drug Development, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Mika K KanekoDepartment of Antibody Drug Development, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Yukinari KatoDepartment of Antibody Drug Development, Graduate School of Medicine, Tohoku University, Sendai, Japan.
Keiichi YamamotoDepartment of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Mikihiro TodaDepartment of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Yasuhiko SuzukiDepartment of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Shiro MurataDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Kazuhiko OhashiDepartment of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Hokkaido University · JPRakuno Gakuen University · JPTohoku University · JPHokkaido Research Organization · JPFuso Pharmaceutical Industries (Japan) · JPUniversity of Miyazaki · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine mycoplasmosis caused by
Indexed as
cattleimmune dysfunctionimmunoinhibitory moleculesMycoplasma bovisPD-1PD-L1prostaglandin E2T-cell exhaustion
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.